Nuo Therapeutics, Inc.
AURX
$1.50
$0.1259.09%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 23.96% | 26.87% | 38.05% | 17.18% | 31.92% |
| Total Depreciation and Amortization | 5.19% | -22.35% | -23.46% | 6.59% | 12.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -166.72% | -60.11% | -34.04% | 758.33% | 31,450.00% |
| Change in Net Operating Assets | 118.37% | 112.20% | -169.09% | 207.84% | -195.33% |
| Cash from Operations | 26.94% | 38.67% | 23.70% | 29.31% | 18.29% |
| Capital Expenditure | -- | -7,842.11% | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -7,842.11% | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -90.61% | -17.96% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -90.61% | -17.96% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -237.44% | -11.50% | 111.79% | 29.78% | 135.23% |